As part of our ongoing series focussing on new registrations in Australia, we have added a product review of the use of Cannabidiol oral solution as adjunctive therapy for seizures associated with Dravet syndrome.
This review discusses current treatment of Dravet sydrome, pharmacological properties, mechanism of action and major studies featuring Cannabidiol oral solution. It also provides commentary and recommendations from Laureate Professor Ingrid Scheffer, a paediatric neurologist and epileptologist at the University of Melbourne and Austin Health.
Please login below to download this issue (PDF)